alvocidib hydrochloride
Term · Oncology and biomedicine · MLC-T-ONC-010012
The hydrochloride salt form of alvocidib, a synthetic N-methylpiperidinyl chlorophenyl flavone compound. As an inhibitor of cyclin-dependent kinase, alvocidib induces cell cycle arrest by preventing phosphorylation of cyclin-dependent kinases (CDKs) and by down-regulating cyclin D1 and D3 expression, resulting in G1 cell cycle arrest and apoptosis. This agent is also a competitive inhibitor of adenosine triphosphate activity.
| Identifier | MLC-T-ONC-010012 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | FLAVO |
| Synonyms | flavopiridol; flavopiridol hydrochloride |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010012",
"term": "alvocidib hydrochloride",
"field": "Oncology and biomedicine",
"definition": "The hydrochloride salt form of alvocidib, a synthetic N-methylpiperidinyl chlorophenyl flavone compound. As an inhibitor of cyclin-dependent kinase, alvocidib induces cell cycle arrest by preventing phosphorylation of cyclin-dependent kinases (CDKs) and by down-regulating cyclin D1 and D3 expression, resulting in G1 cell cycle arrest and apoptosis. This agent is also a competitive inhibitor of adenosine triphosphate activity.",
"abbreviation": "FLAVO",
"synonyms": [
"flavopiridol",
"flavopiridol hydrochloride"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alvocidib-hydrochloride/"
}
Record 932 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.